clinical_trials
Novel ADC Boosts Survival in Pretreated Endometrial Cancer
Confidence86·multiple reportsImportance88NP-EVT-20261110-EC36F04
(MedPage Today) -- Results from the TroFuse-005 trial presented at the annual European Society for Medical Oncology congress showed that the investigational antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) significantly improved...
Read the original at the primary source
Novel ADC Boosts Survival in Pretreated Endometrial Cancer
11/10/2026, 3:31:59 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —